Skip to main content
Livermore
Livermore
中文EN

Embecta Corp.

EMBC
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001872789

In the last 90 days, Embecta Corp. insiders filed 4 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $164.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Embecta Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
4 filings
4 insiders, $557.9K in total
Open-market sells
1 filing
1 insider, $37.0K in total
Insiders trading
5
Net value
+$521.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Embecta Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Embecta Corp.
NameTitleLast reported holdingLast filingFilings, past year
Morris Milton MayoDirector53,828Sep 8, 20262
Kurdikar DevdattPresident and CEO804,919Aug 13, 20262
Elguicze JacobSVP and CFO309,139Aug 13, 20262
Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLO262,915Aug 13, 20262
Hombach Robert J.Director109,587Aug 13, 20262
Casner JeanChief Human Resources Officer85,915Aug 11, 20262
Roth Anthony M.VP, Chief Accounting Officer78,833Jun 2, 20262
Reidy Christopher RDirector70,122Feb 13, 20261
Prange KarenDirector64,581Feb 13, 20261
Pomeroy ClaireDirector66,127Feb 13, 20261
Anderson Carrie LDirector64,581Feb 13, 20261
Curtis ShaunSVP, Global Manuf./Sup. Chain95,324Dec 1, 20251
Melcher David FDirector86,681May 23, 20250
Albritton DavidDirector39,743Feb 14, 20250
Capone BrianVP, CAO & Corp. Controller21,054Nov 28, 20230
Kumar AjaySVP and CHRO28,444Nov 29, 20220
Becton Dickinson & Co10% Owner0Apr 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2026 (view filing)5:13 PM ETSep 44 daysMorris Milton MayoDirectorSSale−6.29K$5.88−$37.0K−10.5%53.8K after
Aug 13, 2026 (view filing)10:50 AM ETAug 121 dayKurdikar DevdattPresident and CEOPPurchase+30.0K$4.70+$140.9K+3.9%804.9K after
Aug 13, 2026 (view filing)10:48 AM ETAug 121 dayElguicze JacobSVP and CFOPPurchase+20.0K$4.67+$93.4K+6.9%309.1K after
Aug 13, 2026 (view filing)10:47 AM ETAug 121 dayMann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLOPPurchase+20.0K$4.99+$99.8K+8.2%262.9K after
Aug 13, 2026 (view filing)10:45 AM ETAug 121 dayHombach Robert J.DirectorPPurchase+45.0K$4.97+$223.8K+69.7%109.6K after
May 23, 2025 (view filing)May 23Same dayMelcher David FDirectorPPurchase+10.0K$10.60+$106.0K+13.0%86.7K after
Feb 25, 2025 (view filing)Feb 25Same dayMelcher David FDirectorPPurchase+13.0K$13.67+$177.7K+20.4%76.7K after
Feb 14, 2025 (view filing)Feb 131 dayMorris Milton MayoDirectorSSale−3.10K$16.38−$50.8K−7.9%36.1K after
Feb 12, 2024 (view filing)Feb 12Same dayMelcher David FDirectorPPurchase+2.00K$16.25+$32.5K+4.6%45.1K after
Sep 8, 2023 (view filing)Sep 8Same dayMelcher David FDirectorPPurchase+6.23K$15.77+$98.3K+29.0%27.7K after
Aug 10, 2023 (view filing)Aug 10Same dayKurdikar DevdattPresident and CEOPPurchase+5.00K$21.81+$109.0K+2.1%244.8K after
Aug 10, 2023 (view filing)Aug 10Same dayMann Jeffrey ZSVP, GC, Head Corp. Dev., SecyPPurchase+4.70K$21.67+$101.8K+9.3%55.3K after
Aug 10, 2023 (view filing)Aug 10Same dayElguicze JacobSVP and CFOPPurchase+4.63K$21.66+$100.2K+7.5%66.0K after
Feb 16, 2023 (view filing)Feb 151 dayMelcher David FDirectorPPurchase+3.10K$32.93+$102.1K+16.9%21.5K afterAmended